Bolt Biotherapeutics, Inc. (BOLT)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in Bolt Biotherapeutics, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $407 for a total return of roughly -95.93%. All prices are adjusted for splits and dividends.
Compare to other instruments
Return
Bolt Biotherapeutics, Inc. had a return of 0.77% year-to-date (YTD) and -57.61% in the last 12 months. Over the past 10 years, Bolt Biotherapeutics, Inc. had an annualized return of -77.85%, while the S&P 500 had an annualized return of 0.75%, indicating that Bolt Biotherapeutics, Inc. did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
1 month | -12.08% | -3.20% |
Year-To-Date | 0.77% | 2.84% |
6 months | -25.57% | 4.19% |
1 year | -57.61% | -12.48% |
5 years (annualized) | -77.85% | 0.75% |
10 years (annualized) | -77.85% | 0.75% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 13.08% | 9.52% | ||||||||||
2022 | -17.78% | -6.08% | 6.47% | -12.16% |
Dividend History
Bolt Biotherapeutics, Inc. doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Bolt Biotherapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Bolt Biotherapeutics, Inc. is 96.84%, recorded on Dec 20, 2022. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-96.84% | Mar 18, 2021 | 445 | Dec 20, 2022 | — | — | — |
-22.7% | Feb 11, 2021 | 11 | Feb 26, 2021 | 7 | Mar 9, 2021 | 18 |
-0.51% | Mar 15, 2021 | 1 | Mar 15, 2021 | 1 | Mar 16, 2021 | 2 |
-0.2% | Mar 10, 2021 | 1 | Mar 10, 2021 | 1 | Mar 11, 2021 | 2 |
Volatility Chart
Current Bolt Biotherapeutics, Inc. volatility is 88.29%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.